That is obscene -- $750k?!
The market cap of $120m is really strange. It should rightly be down in the the ~$20m range.
Basically a couple of pre-clinical assets, with a bit of safety work done with no independent evidence of efficacy apart from "Recce says it works", and a history of moving goalposts and burying results.
I think it's only partly explained by the large family holdings and very good marketing to retail investors.
A real head scratcher...
Ann: Appendix 4E and Unaudited Preliminary Report, page-12
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.5¢ |
Change
0.005(0.98%) |
Mkt cap ! $118.1M | |||
| Open | High | Low | Value | Volume |
| 52.0¢ | 52.0¢ | 51.0¢ | $11.78K | 22.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23945 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 13972 | 2 |
View Market Depth
| Last trade - 11.41am 12/09/2024 (20 minute delay) ? |
| RCE (ASX) Chart |